NCT07064109View on ClinicalTrials.gov

Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients

NARecruitingINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2027

Conditions
ACS - Acute Coronary Syndrome
Interventions
DRUG

Colchicine 0.5 MG Oral Tablet Once Daily

Colchicine 0.5 MG Oral Tablet Once Daily

Trial Locations (1)

200000

RECRUITING

Shanghai Tongji Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Tongji Hospital, Tongji University School of Medicine

OTHER

NCT07064109 - Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients | Biotech Hunter | Biotech Hunter